A new study found that heavy drinkers had a higher risk of brain lesions and proteins associated with Alzheimer's disease.

An overview of endometriosis subtypes, treatment options and costs, according to a recent research review published in JAMA.

The WRAPSODY CIE received premarket approval (PMA) from the US Food and Drug Administration (FDA) in December 2024. Merit began commercialization of the device in the United States in January 2025.

The use of HMME-PDT is associated with a positive response and is well-tolerated among patients with facial port-wine stains.